DPT vaccine lies
[back] Lying
[They have got a cheek to make out DPT is safe and doesn't cause brain damage. They engineered this lie in the UK by fixing a court case. They then said the 900 cases of brain damage they paid out in the past were nothing to do with the vaccine!! (1, 2.]
"The case commenced in October 1987 in front of Lord Justice
Stuart-Smith at the High Court. I was alarmed to discover that it was the Judge who
decided which case he wanted to hear and which witnesses he would allow to be heard and
that there would be a moratorium on all other Legal Aid Certificates. Lord Justice
Stuart-Smith .....found that the Plaintiff had
failed to show on the balance of probabilities that the vaccine could have caused
permanent brain damage in young children. ..... His Lordships decision did not surprise me and others
because he had been deprived of hearing vital evidence from the parents of vaccine damaged
children, their medical experts, independent medical experts from the Vaccine Damaged
Tribunals and reports from the Yellow Card system. Before the case commenced I wrote to
the Lord Chancellor and the Master of the Rolls saying that the case had been chosen to
fail, they replied saying they could intervene. I also wrote to the Learned Clerk to
the Lord Stuart-Smith about the witnesses to be called, he replied saying that this was up
to the Counsel in the case.
There is little doubt the Loveday v Renton case left a lot to be
desired in the interests of natural justice. When was the Loveday case selected when Miss
Loveday had been refused Payment under the Act and had previously been to the court of
appeal on two occasions which had refused her applications. There were hundreds of cases
which could have been selected which had been awarded the Payment and where evidence could
have been called by medical experts."---Wm. H Wain BEM
At Risk: Truth About Vaccines, Lawsuits & Shortages
by Barbara Loe Fisher
MYTH #1: DPT vaccine injury lawsuits in the 1970's and 1980's drove
most drug companies making vaccines out of US market; or specifically, as Offit
states in the June 3, 2007 Boston Globe Op Ed, " at the beginning of the 1980's,
18 companies made vaccines, by the end of the decade, only four were left."
FACT: In 1982, there were four drug companies making and
selling vaccines for children in the U.S.: Merck, Wyeth, Lederle and Connaught.
In 2007, after two decades of mergers and acquisitions, there are six drug
companies making and selling vaccines for children in the U.S.: Merck, Wyeth,
Sanofi Pasteur, GlaxoSmithKline, MedImmune and Novartis. Foreign companies, like
Australia's CSL Biotherapies, are poised to enter the lucrative US vaccine
market soon. There are more than 200 vaccine trials in various stages worldwide
and most vaccines being developed will be targeted by CDC officials and drug
company lobbyists for widespread use in order to guarantee stockholder profits
for vaccine manufacturers.
MYTH #2: Because DPT vaccine injury lawsuits in the 1970's and
1980's drove drug companies out of the US market, vaccine shortages occurred and
continue to occur; specifically, Offit blames "the legacy of pertussis
litigation" for shortages of tetanus vaccine "in 1998," pneumococcal (Prevnar)
vaccine "beginning in 2000" and influenza vaccine "between 2003- 2004."
FACT: In a 2002 Government Accounting Office (GAO)
investigation and report,"Childhood Vaccines: Ensuring an Adequate Supply Poses
Continuing Challenges," the threat of vaccine injury lawsuits was not listed
among reasons for vaccine shortages in the U.S.. Instead, the GAO identified
primary reasons as (1) manufacturing production problems; (2) calls by
immunization policy-making bodies to remove a preservative from vaccines as a
precautionary measure; (3) a manufacturer's decision to cease production of some
vaccines; and (4) greater than- expected demand for a vaccine that had recently
been added to the immunization schedule.
Almost all of the vaccine shortages
that the U.S. has experienced have been due to vaccine manufacturer production
and government regulation compliance problems. Dr Offit should be well aware of
reasons for vaccine shortages in the past decade because he was publicly
identified as a member of the CDC's Advisory Committee on Immunization Practices
(ACIP) from 1998 to 2003.
The shortage of adult tetanus
vaccine occurred in early 2001, not 1998, when Wyeth-Lederle abruptly announced
it had stopped production of tetanus-toxoid containing products, as well as DTaP
vaccine. The 2002 GAO report revealed Wyeth had been planning to leave the DTaP
and tetanus vaccine market but accelerated its departure when it realized it
would have problems responding to FDA requirements to make "significant upgrades
to its facilities where tetanus toxoid was manufactured." In addition, in August
2001, Merck temporarily suspended operations in one of its facilities
manufacturing MMR and Varicella (chicken pox) vaccines to address issues raised
by FDA inspectors during a plant inspection and to make scheduled modifications
to its facility. According to the 2002 GAO report, the time it took to make
plant modifications and difficulties in meeting FDA manufacturing requirements
contributed to shortages of MMR, varicella, DTaP, and Td vaccines between the
end of 2001 and summer of 2002.
The shortage of pneumococcal
vaccine in 2001- 2002, occurred when Wyeth-Lederle aggressively promoted its
vaccine after FDA licensure in 2000 but failed to correctly predict public
demand for the vaccine that made Prevnar the best selling new pharmaceutical
product in 2001. Although failure of supply to meet demand was the main reason
for the shortage, the 2002 GAO report added ""the company's production of the
vaccine was also hampered by ongoing manufacturing problems" and "changes made
in the company's quality assurance procedures" to comply with FDA standards.
The shortage of influenza vaccine
in 2003-2004 and flu-related deaths resulted when a more severe type of
influenza circulating that year (A/Fujian) was not contained in the flu vaccine.
CDC officials, who knew it but didn't tell Americans, publicized the deaths of
children attributed to the Fujian flu in the fall of 2003 and urged that
everyone get vaccinated, which generated a huge demand for flu vaccine that
exceeded supply.
http://www.nvic.org/History/Newsletters/%203770Reaction.pdf
MYTH #3: DPT vaccine does not cause brain inflammation and
permanent brain damage; specifically Offit states that "Subsequent studies of
hundreds of thousands of children showed that the risk of permanent brain damage
was the same in children who had not received the vaccine as in those who had."
FACT: Of all the vaccines which have been routinely used by
children in the past century, the brain damaging effects of the pertussis
(whooping cough) portion of DPT vaccine is among the most well documented in the
scientific literature. Created in 1912, the crude pertussis vaccine basically
consisted of B. pertussis bacteria killed with heat, preserved with
formaldehyde, and injected into children. In the early 1940's, aluminum was
added as an adjuvant and later the mercury preservative, thimerosal, was added
when pertussis was combined with diphtheria and tetanus vaccines to create DPT.
Pertussis vaccine was never studied in large clinical trials before being given
to children in the first half of the 20th century or after it was combined into
DPT and recommended for mass use by the American Academy of Pediatrics in 1947.
The pertussis vaccine's ability to
kill was first signaled in 1933 when T. Madsen reported two babies died within
minutes of vaccination. In 1947, Matthew Brody gave detailed descriptions of two
cases involving brain damage and death after pertussis vaccination. But, it was
the 1948 published case study by Byers and Moll that gave the strongest warning
that children were suffering brain inflammation within 72 hours of pertussis
vaccination and being left with various kinds of brain damage. Forty years
later, the prospective UCLA/FDA study published in Pediatrics in 1981 comparing
DT and DPT vaccines would find that 1 in 875 DPT shots is followed by either a
convulsion or collapse shock episode within 48 hours of vaccination.
Biological mechanisms for pertussis
vaccine induced brain damage center on pertussis toxin (PT), one of the most
lethal toxins in nature. Pertussis toxin is a known neurotoxin, a reliable
inducer of brain inflammation and brain damage, which is why it is used in lab
animals to deliberately induce EAE (experimental autoimmune encephalomyelitis).
Pertussis toxin is implicated in brain inflammation caused by pertussis
(whooping cough) complications as well as pertussis vaccine complications.
Unfortunately, pertussis toxin is also thought to be responsible for stimulating
immunity which is why it remains in DPT, DTaP and Tdap vaccines.. Other
ingredients in DPT vaccine, which have been associated with neuroimmune
dysfunction and may interact synergistically with pertussis toxin to cause
shock, brain damage or death are: endotoxin, aluminum, and mercury.
After decades of reports in the
medical literature that the pertussis portion of DPT vaccine was causing brain
damage in some children, the large, case controlled National Childhood
Encephalopathy Study was conducted in Britain and published in 1981. It
confirmed a statistically significant association between pertussis vaccine or
pertussis-containing vaccines (DPT) and acute brain inflammation leading to
permanent brain damage. An NCES reanalysis 10 years later re-confirmed the
finding. In 1994, the Institute of Medicine, National Academy of Sciences,
published a report validating the conclusions of NCES, stating that " "the
balance of evidence is consistent with a causal relation between DPT and the
forms of chronic nervous system dysfunction in the NCES in those children who
experience a serious acute neurological illness within 7 days after receiving
DPT vaccine."